bluebird bio, Inc. (0HOH.L)

LSE - LSE Prezzo differito. Valuta in USD.

Aggiungi a watchlist

6,21

-0,08

(-1,20%)

Alla chiusura: 07:10PM GMT

Capitalizzazione	3,45M
Beta (5 anni mensile)	0,98
Rapporto PE (ttm)	N/D
EPS (ttm)	-10,43
Prossima data utili	02 mar 2023 - 06 mar 2023
Rendimento e dividendo (forward)	N/D (N/D)
Data ex dividendo	N/D
Stima target 1A	N/D

Tutte

GlobeNewswire
Real Endpoints Marketplace announces collaboration with bluebird bio to help scale delivery of a first-of-its-kind value-based contract for one-time gene therapy
The risk-sharing agreement removes economic uncertainties, enabling regional and mid-sized health plans to provide patients with transfusion-dependent beta-thalassemia access to ZYNTEGLOFLORHAM PARK, N.J., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Real Endpoints, the leading market-access platform and advisory firm, announced a collaboration with bluebird bio, inc. (Nasdaq: BLUE), to provide multiple health plans with access to an innovative, outcomes-based agreement for ZYNTEGLO® (betibeglogene autotem